References
Andersson, G., Larhammar, D., Widmark, E., Servenius, B., Peterson, P. A., and Rask, L.: Class II genes of the human major histocompatibility co complex. Organization and evolutionary relationship of theDR genes.J Biol Chem 262: 8748–8758, 1987
Bell, J. I., Denney, D., Foster, L., Belt, T., Todd, J. A., and McDevitt, H. O.: Allelic variation in the DR subregion of the human major histocompatibility complex.Proc Natl Acad Sci USA 84: 6234–6238, 1987
Berdoz, J., Tiercy, J.-M., Rollini, P., Mach, B., and Gorski, J.: Remarkable sequence conservation of theHLA-DQB2 locus (DX\) within the high polymorphicDQ subregion of the human MHC.Immunogenetics 29: 241–248, 1989
Bohme, J., Andersson, M., Andersson, G., Moller, E., Peterson, P. A., and Rask, L.:HLA-DR genes vary in number between different DR specificities whereas the number ofDQ genes is constant.J Immunol 135: 2149–2155, 1985
Braunstein, N. S. and Germain, R. N.: Allele-specific control of Ia molecule surface expression and conformation: implications for a general model of Ia structure-function relationships.Proc Natl Acad Sci USA 84: 2921–2925, 1987
Brown, J. H., Jardetzky, T., Saper, M. A., Samraoui, B., Bjorkman, P. J., and Wiley, D. C.: A hypothetical model of the foreign antigen binding site of Class II histocompatibility molecules.Nature 332: 845–850, 1988
Clayberger, C., Parham, P., Rothbard, J., Ludwig, D. S., Schoolnik, G. K., and Krensky, A. M.: HLA-A2 peptides can regulate cytolysis by human allgeneic T lymphocytes.Nature 330: 763–765, 1987
de Koster, H. S., Anderson, D. C., and Termijtelen, A.: T cells sensitized to synthetic HLA-DR3 peptide give evidence of continuous presentation of denatured HLA-DR3 molecules by HLA-DP.J Exp Med 169: 1191–1196, 1989
Gregersen, P. K., Shen, M., Song, Q. L., Merryman, P., Degar, T., Seki, T., Maccari, J., Goldberg, D., Murphy, H., Schwenzer, J., Wang, C. Y., Winchester, R. J., Nepom, G. T., and Silver, J.: Molecular diversity of HLA-DR4 haplotypes.Proc Natl Acad Sci USA 83: 2642–2646, 1986a
Gregersen, P. K., Moriuchi, T., Karr, R. W., Obata, F., Maccari, J., Goldberg, D., Winchester, R. J., and Silver, J.: Polymorphism of HLA-DR beta chains in DR4,-7, and-9 haplotypes: implications for the mechanisms of variation.Proc Natl Acad Sci USA 83: 9149–9153, 1986b
Hedley, M. L., Ozato, K., Maryanski, J., Tucker, P. W. and Forman, J.: Expression of mutant H-2d proteins encoded by class I genes which alternatively process the 5' end of their transcripts.J Immunol 143: 1026–1031, 1989
Honeyman, M., Hsu, S. H., Rayment, C., Chan, M. M., and Bashir, H.: First level testing of Dw7 HTC.In E. D. Albert, M. P. Baur, W. R. Mayr (eds.):Histocompatibility Testing 1984, pp. 276–278, Springer, Berlin, 1984
Knowles, R. W., Flomenberg, N., Horibe, K., Winchester, R., Radka, S. F., and Dupont, B.: Complexity of the supertypic HLA-DRw53 specificity: two distinct epitopes differentially expressed on one or all of the DR \-chains depending on the HLA-DR allotype.J Immunol 137: 2618–2626, 1986
Larhammar, D., Servenius, B., Rask, L., and Peterson, P. A.: Characterization of anHLA DR\ pseudogene.Proc Natl Acad Sci USA 82: 1475–1479, 1985
Minami, Y., Weissman, A. E., Samelson, L. E., and Klausner, R. D.: Building a multichain receptor: synthesis, degradation, and assembly of the T-cell antigen receptor.Proc Natl Acad Sci USA 84: 2688–2692, 1987
Mount, S. M.: A catalogue of splice junction sequences.Nucleic Acids Res 10: 459–472, 1982
Mukai, R., Suzuki, M., Yabe, T., Hamaguchi, H., and Maeda, H.: Identification of the MT3 molecule from HLA-DR4, 7 and w9 cell lines.J Immunol 133: 3211–3219, 1984
Okada, K., Boss, J. M., Prentice, H., Spies, T., Mengler, R., Auffrey, C., Lillie, J., Grossberger, D., and Strominger, J.: Gene organization of DC and DX subregions of the human major histocompatibility complex.Proc Natl Acad Sci USA 82: 3410–3414, 1985
Padgett, R. A., Grabowski, P. J., Konarska, M. M., Seiler, S., and Sharp, P. A.: Splicing of messenger RNA precursors.Annu Rev Biochem 55: 1119–1150, 1986
Reed, R. and Maniatis, T.: Intron sequences involved in lariat formation during pre-mRNA splicing.Cell 41: 95–105, 1985
Rogers, J. H.: The origin and evolution of retroposons.Int Rev Cytol 93: 187–279, 1985
Saiki, R. K., Gelfand, D. H., Stoffel, S. J., Higuchi, R., Horn, G. T., Mullis, K. B., and Erlich, H. A.: Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase.Science 239: 487–491, 1988
Sutton, V. R. and Knowles, R. W.: Mapping of a restriction fragment length polymorphism associated with defective DR\4 chain expression to theHLA-DRB1 gene.Hum Immunol 22: 123–134, 1988
Sutton, V. R., Kienzle, B. K., and Knowles, R. W.: An altered splice site is found in theDRB4 gene that is not expressed in HLA-DR7,Dw11 individuals.Immunogenetics 29: 317–322, 1989
Young, J. A. T., Wilkinson, D., Bodmer, W. F., and Trowsdale, J.: Sequence and evolution of HLA-DR7- and DRw53-associated \-chain genes.Proc Natl Acad Sci USA 84: 4929–4933, 1987
Author information
Authors and Affiliations
Additional information
The nucleotide sequence data reported in this paper have been submitted to the GenBank nucleotide sequence database and have been assigned the accession number M30694.
Rights and permissions
About this article
Cite this article
Sutton, V.R., Knowles, R.W. An aberrantDRB4 null gene transcript is found that could encode a novel HLA-DR chain. Immunogenetics 31, 112–117 (1990). https://doi.org/10.1007/BF00661221
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00661221